Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Senestech, Inc. (SNES : NSDQ)

• Company Description    SenesTech, Inc. developed technology for managing animal pest populations through fertility control as opposed to a lethal approach. The Company's fertility control product candidate, ContraPest(R), will be marketed for use initially in controlling rat infestations. SenesTech, Inc. is based in Flagstaff, Arizona. Number of Employees: 27

• Price / Volume Information    Yesterday's Closing Price: $0.48 Daily Weekly Monthly 20 Day Moving Average: 46,635 shares Shares Outstanding: 12.21 (millions) Market Capitalization: $5.86 (millions) Beta: 1.38 52 Week High: $1.92 52 Week Low: $0.39 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -25.09% -15.64% 12 Week -35.90% -29.54% Year To Date -50.95% -37.45%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 23460 NORTH 19TH AVENUE SUITE 110 - PHOENIX,AZ 85027 USA ph: 928-779-4143 fax: - senestech@lythampartners.com http://www.senestech.com

• General Corporate Information    Officers Kenneth Siegel - Chief Executive Officer Jamie Bechtel - Chair of the Board Thomas C. Chesterman - Chief Financial Officer and Treasurer Marc Dumont - Director Delphine Francois Chiavarini - Director Peer Information Senestech, Inc. (BJCT) Senestech, Inc. (CADMQ) Senestech, Inc. (APNO) Senestech, Inc. (UPDC) Senestech, Inc. (IMTIQ) Senestech, Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 81720R208 SIC: 2870 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/11/22 Share - Related Items Shares Outstanding: 12.21 Most Recent Split Date: 2.00 (0.05:1) Beta: 1.38 Market Capitalization: $5.86 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.19 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.79 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/11/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.74 Price/Cash Flow: - Price / Sales: 8.29 EPS Growth vs. Year Ago Period: 13.64% vs. Previous Quarter: 9.52% Sales Growth vs. Year Ago Period: 121.59% vs. Previous Quarter: 15.38% ROE 03/31/22 - -78.77 12/31/21 - -62.99 09/30/21 - -67.90 ROA 03/31/22 - -70.01 12/31/21 - -56.54 09/30/21 - -59.36 Current Ratio 03/31/22 - 9.51 12/31/21 - 11.30 09/30/21 - 14.75 Quick Ratio 03/31/22 - - 12/31/21 - 10.24 09/30/21 - 13.59 Operating Margin 03/31/22 - -1,241.73 12/31/21 - -1,378.00 09/30/21 - -1,490.15 Net Margin 03/31/22 - -1,241.73 12/31/21 - -1,378.00 09/30/21 - -1,490.15 Pre-Tax Margin 03/31/22 - -1,241.73 12/31/21 - -1,378.00 09/30/21 - -1,485.98 Book Value 03/31/22 - 0.65 12/31/21 - 0.82 09/30/21 - 1.01 Inventory Turnover 03/31/22 - 0.42 12/31/21 - 0.37 09/30/21 - 0.47 Debt-to-Equity 03/31/22 - 0.00 12/31/21 - 0.00 09/30/21 - 0.00 Debt-to-Capital 03/31/22 - 0.00 12/31/21 - 0.00 09/30/21 - 0.00

Powered by Zacks Investment Research ©